Optel Group, founded in 1989 and headquartered in Canada, operates within the software industry, specifically focusing on supply chain management (SCM) software. With a workforce of 501 to 1,000 employees, the company has established itself as a provider of solutions that enhance product traceability and compliance within the pharmaceutical sector. A notable case study highlights the implementation of Optel's VerifyBrand™ platform by TruPharma, a pharmaceutical distributor, which enabled the company to achieve compliance with the Drug Supply Chain Security Act (DSCSA) in under four months. The case study illustrates the critical role of serialization and traceability in meeting regulatory requirements and the importance of selecting an efficient technology platform to manage these operations. Optel Group's offerings are geared towards ensuring that companies in the pharmaceutical supply chain can effectively manage serialization and data exchange with their trading partners, thereby facilitating compliance and operational efficiency. The company's expertise is particularly relevant in addressing the challenges posed by evolving regulatory landscapes in the pharmaceutical industry.